Unity Biotechnology, Inc. Forms 3, 4 and 5: Stock Options
Statements of beneficial ownership filed with the SEC by officers, directors and 10% owners: 16 rows in 2022. Transaction codes are the SEC's. Shares and prices are split-adjusted; the as-filed figure is underneath.
- 2022-11-18: Reporting owner Ghosh Anirvan; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-11-18: Reporting owner Dananberg Jamie; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-11-18: Reporting owner Nguyen Alexander Hieu; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
- 2022-11-18: Reporting owner Sullivan Lynne Marie; Form 4; Security Stock Option (Right to Buy); Transaction A Grant, award or other acquisition pursuant to Rule 16b-3(d).
| Transaction date | Reporting owner | Form | Security | Transaction | Shares | Price | Price that day | Filing |
|---|---|---|---|---|---|---|---|---|
| 2022-11-18 | Ghosh Anirvan Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $2.38 exercise price | 2022-11-21 | |
| 2022-11-18 | Dananberg Jamie Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $2.38 exercise price | 2022-11-21 | |
| 2022-11-18 | Nguyen Alexander Hieu Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +65,000 65,000 owned after | $2.38 exercise price | 2022-11-21 | |
| 2022-11-18 | Sullivan Lynne Marie Officer (CFO & Head of Corp. Dev.) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +80,000 80,000 owned after | $2.38 exercise price | 2022-11-21 | |
| 2022-06-24 | O'Neill Gilmore Neil Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $0.59 exercise price | 2022-06-27 | |
| 2022-06-24 | Samuels Camille D Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $0.59 exercise price | 2022-06-27 | |
| 2022-06-24 | Roberts Margo R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $0.59 exercise price | 2022-06-27 | |
| 2022-06-24 | Leonard Keith R Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $0.59 exercise price | 2022-06-27 | |
| 2022-06-24 | BERNS PAUL L Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $0.59 exercise price | 2022-06-27 | |
| 2022-06-24 | Samar Michael P. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +2,055 2,055 owned after | $0.59 exercise price | 2022-06-27 | |
| 2022-06-24 | David Nathaniel E Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +25,000 25,000 owned after | $0.59 exercise price | 2022-06-27 | |
| 2022-05-25 | Samar Michael P. Director | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +50,000 50,000 owned after | $0.76 exercise price | 2022-05-26 | |
| 2022-02-09 | Dananberg Jamie Officer (Chief Medical Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +183,333 183,333 owned after | $1.06 exercise price | 2022-02-15 | |
| 2022-02-09 | Nguyen Alexander Hieu Officer (See Remarks) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +183,333 183,333 owned after | $1.06 exercise price | 2022-02-15 | |
| 2022-02-09 | Sullivan Lynne Marie Officer (CFO & Head of Corp. Dev.) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +200,000 200,000 owned after | $1.06 exercise price | 2022-02-15 | |
| 2022-02-09 | Ghosh Anirvan Director, Officer (Chief Executive Officer) | 4 | Stock Option (Right to Buy) Derivative · Direct | A Grant, award or other acquisition pursuant to Rule 16b-3(d) | +566,667 566,667 owned after | $1.06 exercise price | 2022-02-15 |